Neurotech Pharmaceuticals, Inc.
Derek Barnett has extensive work experience in the pharmaceutical industry, with a focus on quality and compliance. Derek currently serves as the Head of Compliance at Neurotech Pharmaceuticals, Inc. Prior to this, they were the Director at Bradford Soap Works. Derek has also held positions as the Director of Quality & Compliance at Denison Pharmaceuticals and the Director of Quality at Bradford Soap Works. Derek has also worked as a Quality Manager at Diversified Distribution and as a QA Supplier Quality Manager at Alexion Pharmaceuticals, Inc. Earlier in their career, Derek worked as an Account Manager at Shuster Labs, a Technical Sales Representative at Brand-Nu Laboratories, Inc., a Materials Manager at Dow Biopharmaceutical Contract, and a Senior Analyst at Wyeth Pharmaceuticals S.A./N.V.
Derek Barnett attained their Bachelor's degree in Biology, General from Rhode Island College, completing their academic journey between 1998 and 2002.
Neurotech Pharmaceuticals, Inc.
Neurotech Pharmaceuticals, Inc. is a privately held biotech company located in Cumberland, Rhode Island. Neurotech has spent years developing the science, technology, team and manufacturing behind NT-501. As a result of a unique partnership and clear direction, we are focused on bringing a long-term treatment to Macular Telangiectasia (MacTel) patients. Our team is focused on bringing to market this treatment designed to slow the progression of MacTel and the vision impairments it causes in patients who don't have another treatment option. Our goal is to help these patients sustain their quality of life.